Better ways to reach LGBTQ+ people with cancer
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
This project tries different ways to reach and sign up LGBTQ+ people with cancer so they can take part in cancer studies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11364813 on NIH RePORTER |
What this research studies
If you've had cancer and identify as LGBTQ+, this project will test two main ways to find and invite people like you: online outreach and using sexual orientation and gender identity (SOGI) entries in clinic records. The team will build on past success recruiting over 400 gay and bisexual prostate cancer patients and will expand to include sexual minority women and transgender or non-binary cancer patients. Some people may be contacted through online ads or social networks, while others may be reached through participating cancer clinics that collect SOGI information in electronic medical records. The goal is to find reliable, respectful ways to include more LGBTQ+ people in cancer research.
Who could benefit from this research
Good fit: Adults with a current or past cancer diagnosis who identify as a sexual minority (gay, bisexual, lesbian) or as transgender or non-binary are the ideal candidates.
Not a fit: People without a cancer diagnosis or who do not identify as sexual or gender minorities are unlikely to be eligible or directly helped by this project.
Why it matters
Potential benefit: If successful, more LGBTQ+ patients could be included in cancer studies, leading to research that better reflects their needs and improves care.
How similar studies have performed: Related online and clinic-based recruitment methods have successfully enrolled large samples of gay and bisexual prostate cancer patients, but applying these methods to sexual minority women and transgender/non-binary patients is newer.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Rosser, B R Simon — University of Minnesota
- Study coordinator: Rosser, B R Simon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.